PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32669383-10 2020 Our results indicate that age-related increases in IL-6 levels reduce progesterone substrate availability, resulting in a decline in allopregnanolone levels and an increase in corticosterone. Progesterone 70-82 interleukin 6 Mus musculus 51-55 11883745-6 2002 RESULTS: In situ hybridization revealed IL-1alpha and IL-6 mRNA localization in normal, dormant and activated blastocysts and a differential expression was observed in relation to the exposure to progesterone and oestrogen. Progesterone 196-208 interleukin 6 Mus musculus 54-58 8920166-5 1996 Progesterone (10(-7) M) modestly (40%) reduced the levels of IL-6 mRNA and protein during culture, whereas LPS dramatically (8-fold) and rapidly induced IL-6 and IL-1 beta mRNAs and proteins. Progesterone 0-12 interleukin 6 Mus musculus 61-65 1505448-10 1992 In addition, there was a synergistic effect of E plus progesterone on inhibition of IL-6 secretion by USC. Progesterone 54-66 interleukin 6 Mus musculus 84-88 1577194-0 1992 Interleukin-1, interleukin-6, and tumor necrosis factor alpha are produced in the mouse uterus during the estrous cycle and are induced by estrogen and progesterone. Progesterone 152-164 interleukin 6 Mus musculus 15-28 1577194-9 1992 Significant amounts of IL-6 and TNF alpha mRNA appeared only following the exposure of ovariectomized mice to estrogen plus progesterone. Progesterone 124-136 interleukin 6 Mus musculus 23-27 1541679-4 1992 Testosterone and progesterone (but not 17 alpha-estradiol) also inhibited IL-6, but their effective concentrations were two orders of magnitude higher than 17 beta-estradiol. Progesterone 17-29 interleukin 6 Mus musculus 74-78 34699875-8 2021 M1 marks such as tumor necrosis factor alpha (TNF-alpha), inducible NOS(iNOS), interleukin-6 (IL-6), and Fc receptor (CD16 and CD32) significantly downregulated by progesterone treatment whether at 3 days or 7 days after ONC. Progesterone 164-176 interleukin 6 Mus musculus 79-92 34699875-8 2021 M1 marks such as tumor necrosis factor alpha (TNF-alpha), inducible NOS(iNOS), interleukin-6 (IL-6), and Fc receptor (CD16 and CD32) significantly downregulated by progesterone treatment whether at 3 days or 7 days after ONC. Progesterone 164-176 interleukin 6 Mus musculus 94-98 12516657-2 2002 Here we analyze whether progesterone (Pg) and estrogen (E2) affect asymmetric antibody synthesis by modulating IL-6 production in hybridoma cells. Progesterone 24-36 interleukin 6 Mus musculus 111-115 12516657-11 2002 Finally, mainly Pg but also E2 increased IL-6 synthesis, although IL-6 levels did not correlate with asymmetric antibodies synthesized in the presence of E2 or Pg. Progesterone 16-18 interleukin 6 Mus musculus 41-45 29566712-6 2018 IL1ss and IL6 had a subtle but significant negative effect on cell viability and testosterone concentrations, with a marked significant decrease in progesterone concentration at all concentrations investigated. Progesterone 148-160 interleukin 6 Mus musculus 10-13 18001439-15 2007 Progesterone reduced the LPS-induced increase in IL-6 production and this may be one of the ways that progesterone reduces the risk of preterm labor. Progesterone 102-114 interleukin 6 Mus musculus 49-53